Ajanta Pharma Limited has submitted a regulatory intimation under SEBI Listing Regulations 29(1)(e) and 42 regarding an upcoming Board meeting.
The Board of Directors meeting is scheduled for Thursday, 30th July 2026. The agenda includes:
- Consideration and taking on record the unaudited financial results for the first quarter ended 30th June 2026
- Consideration of declaration of first interim dividend for the financial year ending 31st March 2027
- Fixation of Wednesday, 5th August 2026 as the Record Date for the payment of interim dividend, if declared
The company references its previous communication dated 20th July 2026 regarding the Board meeting schedule. The intimation serves as formal notice to the stock exchanges as required under SEBI listing regulations.